資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34105
|
| 標題: | Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression |
| 作者: | Chen, Ming-Jenn
Chen, Po-Ming
Wang, Lee
Shen, Ching-Ju
Chen, Chi-Yi
Lee, Huei |
| 貢獻者: | Chi Mei Med Ctr, Dept Surg
Chia Nan Univ Pharm & Sci, Coll Leisure & Recreat Management, Dept Sports Management
Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery
Chung Shan Med Univ, Dept Publ Hlth
Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Gynecol & Obstet, Coll Med
Chung Shan Med Univ Hosp, Dept Surg |
| 關鍵字: | NKX2-1
TNFSF10
cisplatin
p53 mutational status
lung adenocarcinoma |
| 日期: | 2020 |
| 上傳時間: | 2022-11-18 11:24:08 (UTC+8) |
| 出版者: | E-Century Publishing Corp |
| 摘要: | NKX2-1 was shown to enhance cisplatin sensitivity in KRAS-mutated cells, but it conferred cisplatin resistance in EGFR-mutated lung adenocarcinoma cells. However, NKX2-1 as a dual role in tumor progression depended on p53 mutational status via modulation of the NF-kappa B pathway. We hypothesized that NKX2-1 may confer cisplatin resistance in p53-mutated (p53-MT) lung adenocarcinoma cells but may enhance cisplatin sensitivity in wild-type (p53-WT) cells. In the present study, six p53-MT and -p53-WT cell lines were treated with various concentrations of cisplatin to calculate the inhibitory concentration of cisplatin for 50% cell viability (IC50). The IC50 value was positively correlated with NKX2-1 expression in the p53-MT cells but negatively correlated in the p53-WT cells. TNFSF10 was identified in a microarray analysis as a potential candidate responsible for NKX2-1-mediated apoptosis induced by cisplatin. The retrospective study evaluated 97 surgically resected lung adenocarcinoma patients receiving cisplatinbased chemotherapy to explore the possible association between NKX2-1 expression and tumor response. Patients with higher TNFSF10 mRNA levels, as determined by real-time reverse transcription-polymerase Chain Reaction (RT-PCR), typically showed an favorable response when compared with patients with lower TNFSF10 mRNA levels. Additionally, the association of higher TNFSF10 mRNA levels with favorable response was only revealed in p53-WT patients, not in p53-MT patients. Higher NKX2-1 mRNA levels were associated with an unfavorable response in patients with p53-MT tumors but a favorable response in patients with p53-WT tumors. In summary, modulation of TNFSF10 expression by NKX2-1 may be a potential indicator for predicting the response to cisplatin-based chemotherapy in patients with lung adenocarcinomas. |
| 關聯: | American Journal of Cancer Research, v.10, n.4, pp.9 |
| 顯示於類別: | [運動管理系] 期刊論文
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
